BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27254269)

  • 1. Molecular markers in pituitary tumors.
    Robertson AM; Heaney AP
    Curr Opin Endocrinol Diabetes Obes; 2016 Aug; 23(4):324-30. PubMed ID: 27254269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pituitary oncogenes.
    Heaney AP; Melmed S
    Endocr Relat Cancer; 2000 Mar; 7(1):3-15. PubMed ID: 10808192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis of pituitary tumors.
    Farrell WE; Clayton RN
    Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary adenoma pathogenesis: an update.
    Rostad S
    Curr Opin Endocrinol Diabetes Obes; 2012 Aug; 19(4):322-7. PubMed ID: 22617628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to use microRNAs as therapeutic targets.
    Gentilin E; Degli Uberti E; Zatelli MC
    Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):629-639. PubMed ID: 27923456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary neoplasia.
    Melmed S
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):81-92. PubMed ID: 7913031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular aspects of pituitary tumors].
    Mełeń-Mucha G
    Endokrynol Pol; 2005; 56(3):333-8. PubMed ID: 16350728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms Underlying Pituitary Pathogenesis.
    Sapochnik M; Nieto LE; Fuertes M; Arzt E
    Biochem Genet; 2016 Apr; 54(2):107-19. PubMed ID: 26718581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms.
    Srirangam Nadhamuni V; Korbonits M
    Endocr Rev; 2020 Dec; 41(6):821-46. PubMed ID: 32201880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenesis and mutagenesis of pituitary tumors.
    Sonabend AM; Musleh W; Lesniak MS
    Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S3-14. PubMed ID: 17004855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary tumors: prognostic indicators.
    Saeger W
    Endocrine; 2005 Oct; 28(1):57-66. PubMed ID: 16311411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and Target Genes in Pituitary Adenomas.
    Feng Y; Mao ZG; Wang X; Du Q; Jian M; Zhu D; Xiao Z; Wang HJ; Zhu YH
    Horm Metab Res; 2018 Mar; 50(3):179-192. PubMed ID: 29351706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors.
    Prezant TR; Levine J; Melmed S
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1388-91. PubMed ID: 9543172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
    Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
    Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Welcoming the new WHO classification of pituitary tumors 2017: revolution in TTF-1-positive posterior pituitary tumors.
    Shibuya M
    Brain Tumor Pathol; 2018 Apr; 35(2):62-70. PubMed ID: 29500747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary carcinomas.
    Colao A; Ochoa AS; Auriemma RS; Faggiano A; Pivonello R; Lombardi G
    Front Horm Res; 2010; 38():94-108. PubMed ID: 20616500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatin remodeling and histone modifications in pituitary tumors.
    Tateno T; Zhu X; Asa SL; Ezzat S
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):66-70. PubMed ID: 20060434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.
    Bottoni A; Zatelli MC; Ferracin M; Tagliati F; Piccin D; Vignali C; Calin GA; Negrini M; Croce CM; Degli Uberti EC
    J Cell Physiol; 2007 Feb; 210(2):370-7. PubMed ID: 17111382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness.
    Yu G; Li C; Xie W; Wang Z; Gao H; Cao L; Hao L; Zhang Y
    Oncol Rep; 2017 Aug; 38(2):1140-1148. PubMed ID: 28656268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics and proteomics of pituitary tumors.
    Asa SL; Ezzat S
    Endocrine; 2005 Oct; 28(1):43-7. PubMed ID: 16311409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.